Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 102, n° 8-9
pages 617-624 (août 2009)
Doi : 10.1016/j.acvd.2009.05.010
Received : 27 Mars 2009 ;  accepted : 18 May 2009
Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation
Analyse comparative de la réendothélialisation de stents actifs au paclitaxel et au zotarolimus en imagerie par cohérence optique six mois après implantation
 

Figure 1




Figure 1 : 

Drug-eluting stent analysis on optical coherence tomography millimetric images: top, qualitative strut analysis. A. Covered. B. Non-covered. C. Malapposed. D. Facing collateral. Bottom, quantitative analysis: intrastent area (green), lumen area (red), coverage thickness per strut (red arrows).


Figure 2




Figure 2 : 

Distribution of strut coverage thickness in paclitaxel-eluting stent (PES) and zacrolimus-eluting stent (ZES) groups.


Figure 3




Figure 3 : 

Examples of optical coherence tomography images. A. Paclitaxel-eluting stent, 3.0×20mm, neointimal hyperplasia area 13%, mean neointimal hyperplasia thickness 95μm, 100% covered struts. B. Zacrolimus-eluting stent, 4.0×9mm, neointimal hyperplasia area 26%, mean neointimal hyperplasia thickness 270μm, 100% covered struts. C. Zacrolimus-eluting stent, 2.5×8mm, neointimal hyperplasia area 47%, mean neointimal hyperplasia thickness 375μm, 100% covered struts. D. Paclitaxel-eluting stent, 2/11 struts malapposed. E. Paclitaxel-eluting stent, 6/19 struts non-covered, 68% covered. F. Paclitaxel-eluting stent, 2/12 struts facing collateral branch.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline